Application for this study are now closed
Browse our other trials that are currently recruiting
CM8720s RSV Vaccine
Fusion Clinical Research, Norwood (formerly Travel Bug Vaccination Clinic)
RSV VACCINE STUDY FOR 60-80 YEAR OLDS, REGISTER YOUR INTEREST NOW
ANTICIPATED START DATE – MAY 2021
Respiratory Syncitial Virus (RSV) is a leading cause of severe lower respiratory tract (LRT) disease in elderly populations.
When an adult gets RSV infection, they typically have mild cold-like symptoms. But RSV can sometimes lead to serious conditions such as Pneumonia (infection of the lungs).
Eligibility requirements
- Age: 60-80 year olds
- Sex: Males and females
- BMI: < = 40
- Medication: No inhaled or systemic corticosteroids
- Medical History: Stable chronic disease permitted
- Smoking History: Not exclusionary
Overnight Stays
- 0
Outpatient Visits
- 14-17 visits (depends on cohort) over approx. 1 year
Payment/Remuneration
- Approx. $2600 -$3200